These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 9887339)
21. MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice. Tomé S; Manley K; Simard JP; Clark GW; Slean MM; Swami M; Shelbourne PF; Tillier ER; Monckton DG; Messer A; Pearson CE PLoS Genet; 2013; 9(2):e1003280. PubMed ID: 23468640 [TBL] [Abstract][Full Text] [Related]
22. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Kennedy L; Evans E; Chen CM; Craven L; Detloff PJ; Ennis M; Shelbourne PF Hum Mol Genet; 2003 Dec; 12(24):3359-67. PubMed ID: 14570710 [TBL] [Abstract][Full Text] [Related]
23. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice. Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884 [TBL] [Abstract][Full Text] [Related]
24. Weight loss in Huntington disease increases with higher CAG repeat number. Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372 [TBL] [Abstract][Full Text] [Related]
25. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death. Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356 [TBL] [Abstract][Full Text] [Related]
26. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Lin CH; Tallaksen-Greene S; Chien WM; Cearley JA; Jackson WS; Crouse AB; Ren S; Li XJ; Albin RL; Detloff PJ Hum Mol Genet; 2001 Jan; 10(2):137-44. PubMed ID: 11152661 [TBL] [Abstract][Full Text] [Related]
27. HD CAG-correlated gene expression changes support a simple dominant gain of function. Jacobsen JC; Gregory GC; Woda JM; Thompson MN; Coser KR; Murthy V; Kohane IS; Gusella JF; Seong IS; MacDonald ME; Shioda T; Lee JM Hum Mol Genet; 2011 Jul; 20(14):2846-60. PubMed ID: 21536587 [TBL] [Abstract][Full Text] [Related]
28. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype. Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255 [TBL] [Abstract][Full Text] [Related]
29. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene. Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003 [TBL] [Abstract][Full Text] [Related]
30. Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. Goula AV; Berquist BR; Wilson DM; Wheeler VC; Trottier Y; Merienne K PLoS Genet; 2009 Dec; 5(12):e1000749. PubMed ID: 19997493 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats. Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926 [TBL] [Abstract][Full Text] [Related]
32. Chromosome substitution strain assessment of a Huntington's disease modifier locus. Ramos EM; Kovalenko M; Guide JR; St Claire J; Gillis T; Mysore JS; Sequeiros J; Wheeler VC; Alonso I; MacDonald ME Mamm Genome; 2015 Apr; 26(3-4):119-30. PubMed ID: 25645993 [TBL] [Abstract][Full Text] [Related]
33. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Manley K; Shirley TL; Flaherty L; Messer A Nat Genet; 1999 Dec; 23(4):471-3. PubMed ID: 10581038 [TBL] [Abstract][Full Text] [Related]
34. Verification of somatic CAG repeat expansion by pre-PCR fractionation. Hunter JM; Crouse AB; Lesort M; Johnson GV; Detloff PJ J Neurosci Methods; 2005 May; 144(1):11-7. PubMed ID: 15848234 [TBL] [Abstract][Full Text] [Related]
35. The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Woodman B; Butler R; Landles C; Lupton MK; Tse J; Hockly E; Moffitt H; Sathasivam K; Bates GP Brain Res Bull; 2007 Apr; 72(2-3):83-97. PubMed ID: 17352931 [TBL] [Abstract][Full Text] [Related]
36. Gametic but not somatic instability of CAG repeat length in Huntington's disease. MacDonald ME; Barnes G; Srinidhi J; Duyao MP; Ambrose CM; Myers RH; Gray J; Conneally PM; Young A; Penney J J Med Genet; 1993 Dec; 30(12):982-6. PubMed ID: 8133508 [TBL] [Abstract][Full Text] [Related]
37. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice. Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194 [TBL] [Abstract][Full Text] [Related]
38. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Mangiarini L; Sathasivam K; Seller M; Cozens B; Harper A; Hetherington C; Lawton M; Trottier Y; Lehrach H; Davies SW; Bates GP Cell; 1996 Nov; 87(3):493-506. PubMed ID: 8898202 [TBL] [Abstract][Full Text] [Related]